Reference for CILENGITIDE. Search for CILENGITIDE

AI searches containing CILENGITIDE

CILENGITIDE

Cilengitide

Chemical compound

Cilengitide (EMD 121974) is a molecule designed and synthesized at the Technical University of Munich in collaboration with Merck KGaA in Darmstadt. It

Cilengitide

Arginylglycylaspartic acid

Chemical compound

cardiovascular disease and cancer, including eptifibatide, tirofiban and cilengitide. These drugs inhibit integrin binding. PET radiotracers such as fluciclatide

Arginylglycylaspartic acid

Arginylglycylaspartic_acid

Integrin

Transmembrane receptors involved in cellular adhesion and signalling

integrin bound to a small ligand containing the RGD-sequence, the drug cilengitide. As detailed above, this finally revealed why divalent cations (in the

Integrin

List of drugs: Ci

cilansetron (INN) cilastatin (INN) cilazapril (INN) cilazaprilat (INN) cilengitide (USAN) cilmostim (INN) cilnidipine (INN) cilobamine (INN) cilobradine

List of drugs: Ci

List_of_drugs:_Ci

Tina Young Poussaint

American radiologist and academic

Boyett, James M.; Kun, Larry E. (2008-02-20). "Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors: Pediatric Brain Tumor Consortium

Tina Young Poussaint

Tina_Young_Poussaint

Short linear motif

include the MDM2 motif analog Nutlin-3 and integrin targeting RGD-mimetic Cilengitide: Nutlin-3 antagonises the interaction of MDM2's SWIB domain with p53

Short linear motif

Short_linear_motif

Index of oncology articles

828 – CI-1033 – CI-958 – CI-980 – CI-994 – ciclosporin – cidofovir – cilengitide – cimetidine – Cipro – ciprofloxacin – circulatory system – cirrhosis

Index of oncology articles

Index_of_oncology_articles